2016 News Releases

Keyword Search
 
2016 | 2015 | 2014 | 2013 | 2012
DateTitle 
02/04/16Ian Massey, President and CEO of StemCells, Inc., to Participate on a Regenerative Medicine Panel at Source Capital Group’s 2016 Disruptive Growth and Healthcare Conference
NEWARK, Calif., Feb. 04, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Ian Massey, President and CEO of StemCells, Inc., will participate on a regenerative medicine panel at Source Capital Group’s 2016 Disruptive Growth and Healthcare Conference. The panel will take place on Feb. 10, at 1:30 p.m., Eastern Standard Time, at the Convene Conference Center, 730 3rd Avenue, in New York City. The panel will be moderated by Todd Fromer, principal of KCSA Strategic Commun... 
Printer Friendly Version
01/28/16StemCells, Inc. to Participate at the 2016 BIO CEO Conference and Source Capital Group’s 2016 Disruptive Growth and Healthcare Conference
StemCells, Inc. Was Voted the 2016 Winner “Buzz of BIO” Public Company NEWARK, Calif., Jan. 28, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that management will make presentations on the Company's programs, pipeline and operations at two upcoming conferences in February. The Company will be presenting at the 2016 BIO CEO Conference on Feb. 8 at 2:30 p.m. Eastern Standard Time at the Waldorf Astoria in New York City. StemCells, Inc. was recognized as the most inno... 
Printer Friendly Version
01/11/16StemCells, Inc. CEO Martin McGlynn Passes Baton to President and COO Ian Massey
Experienced Biotech Leader to Become Next Chief Executive Officer NEWARK, Calif., Jan. 11, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (NASDAQ:STEM), a world leader in the research and development of cell-based therapeutics for the treatment of central nervous system disorders, today announced that Dr. Ian Massey, its President and Chief Operating Officer, has been appointed by the Board of Directors to succeed Martin McGlynn as the Company’s Chief Executive Officer, effective January 18, 2016. ... 
Printer Friendly Version
01/06/16StemCells, Inc. to Participate at the 8th Annual Biotech Showcase Investor Conference
Management Will Present an Update on the Company’s Programs, Pipeline and Operations NEWARK, Calif., Jan. 06, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that management will make a presentation on the Company's programs, pipeline and operations at the 8th Annual Biotech Showcase Investor Conference.  Management is scheduled to speak at 4:30 p.m. Pacific Standard Time on Monday, January 11, at the Parc 55 Hotel, located at 55 Cyril Magnin Street, San Francisco. A... 
Printer Friendly Version